Urology TimesAndrew A. Wagner, MD, et al. - It is now widely accepted that accurate measurement of functional outcomes following prostate cancer treatment is best accomplished by using validated patient questionnaires to query patient health-related quality of life (HRQoL) outcomes. Urologists are familiar with the clinical impact of such patient-reported HRQoL instruments because the advent and widespread implementation of one such instrument, the American Urological Association Symptom Index (International Prostate Symptom Score), accelerated the development of new treatments for BPH

More: continued here

Bookmark to: